Key Financial Data Of Group

KYORIN Pharmaceutical Co., Ltd. - Filing #7330327

Concept 2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
As at
2024-03-31
As at
2024-03-31
2022-04-01 to
2023-03-31
As at
2023-03-31
As at
2023-03-31
2022-04-01 to
2023-03-31
2021-04-01 to
2022-03-31
2021-04-01 to
2022-03-31
As at
2022-03-31
As at
2022-03-31
As at
2021-03-31
2020-04-01 to
2021-03-31
2020-04-01 to
2021-03-31
As at
2021-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
2019-04-01 to
2020-03-31
As at
2020-03-31
Key financial data of group
Business results of group
Net sales
105,157,000,000 JPY
119,532,000,000 JPY
JPY
113,270,000,000 JPY
JPY
105,534,000,000 JPY
JPY
102,904,000,000 JPY
JPY
109,983,000,000 JPY
Operating revenue
JPY
5,853,000,000 JPY
6,575,000,000 JPY
7,189,000,000 JPY
7,244,000,000 JPY
Ordinary profit (loss)
7,417,000,000 JPY
6,602,000,000 JPY
2,975,000,000 JPY
5,827,000,000 JPY
3,960,000,000 JPY
5,569,000,000 JPY
4,585,000,000 JPY
6,447,000,000 JPY
4,482,000,000 JPY
8,175,000,000 JPY
Profit (loss) attributable to owners of parent
5,322,000,000 JPY
4,723,000,000 JPY
3,932,000,000 JPY
6,130,000,000 JPY
6,149,000,000 JPY
Comprehensive income
7,949,000,000 JPY
3,986,000,000 JPY
3,625,000,000 JPY
6,276,000,000 JPY
3,674,000,000 JPY
Net assets
130,783,000,000 JPY
119,409,000,000 JPY
64,935,000,000 JPY
125,461,000,000 JPY
124,507,000,000 JPY
64,952,000,000 JPY
124,661,000,000 JPY
64,812,000,000 JPY
122,710,000,000 JPY
64,642,000,000 JPY
Total assets
177,679,000,000 JPY
163,527,000,000 JPY
99,304,000,000 JPY
176,045,000,000 JPY
171,924,000,000 JPY
95,619,000,000 JPY
167,126,000,000 JPY
95,391,000,000 JPY
171,160,000,000 JPY
95,126,000,000 JPY
Net assets per share
2,276.52
2,078.28
1,118.53
2,189.40
2,172.83
1,118.83
2,175.52
1,116.42
2,142.07
1,113.61
Basic earnings (loss) per share
923.33
92.74
51.78
82.44
67.51
68.62
77.80
106.99
77.11
107.35
Diluted earnings per share
Equity-to-asset ratio
0.736 xbrli:pure
0.730 xbrli:pure
0.654 xbrli:pure
0.713 xbrli:pure
0.724 xbrli:pure
0.679 xbrli:pure
0.746 xbrli:pure
0.679 xbrli:pure
0.717 xbrli:pure
0.680 xbrli:pure
Rate of return on equity
0.575 xbrli:pure
0.042 xbrli:pure
0.046 xbrli:pure
0.038 xbrli:pure
0.060 xbrli:pure
0.032 xbrli:pure
0.070 xbrli:pure
0.050 xbrli:pure
0.069 xbrli:pure
0.050 xbrli:pure
Price-earnings ratio
1.96 xbrli:pure
19.54 xbrli:pure
32.91 xbrli:pure
20.67 xbrli:pure
26.32 xbrli:pure
25.90 xbrli:pure
24.78 xbrli:pure
18.02 xbrli:pure
28.50 xbrli:pure
20.48 xbrli:pure
Net cash provided by (used in) operating activities
1,549,000,000 JPY
2,008,000,000 JPY
6,346,000,000 JPY
5,189,000,000 JPY
7,739,000,000 JPY
Net cash provided by (used in) investing activities
-3,187,000,000 JPY
-6,275,000,000 JPY
-2,560,000,000 JPY
-4,259,000,000 JPY
-2,943,000,000 JPY
Net cash provided by (used in) financing activities
-3,347,000,000 JPY
-3,363,000,000 JPY
-4,112,000,000 JPY
-4,918,000,000 JPY
-5,117,000,000 JPY
Cash and cash equivalents
13,886,000,000 JPY
18,816,000,000 JPY
26,289,000,000 JPY
26,476,000,000 JPY
30,509,000,000 JPY
Number of employees
2,042 xbrli:pure
1,353 xbrli:pure
117 xbrli:pure
2,138 xbrli:pure
2,222 xbrli:pure
115 xbrli:pure
2,243 xbrli:pure
114 xbrli:pure
2,271 xbrli:pure
113 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.